发明名称 ARTIFICIAL TRANSCRIPTION FACTORS ENGINEERED TO OVERCOME ENDOSOMAL ENTRAPMENT
摘要 The invention relates to an artificial transcription factor comprising a polydactyl zinc finger protein targeting specifically a gene promoter, engineered to overcome endosomal entrapment after transduction into cells. Such artificial transcription factor comprises a polydactyl zinc finger protein fused to an inhibitory or activatory protein domain, a nuclear localization sequence, a protein transduction domain, and an endosome-specific protease-recognition site. These transducible artificial transcription factors are particularly useful for the treatment of diseases caused or modulated by membrane-bound receptor proteins, nuclear receptor proteins or products of haploinsufficient genes.
申请公布号 US2016046682(A1) 申请公布日期 2016.02.18
申请号 US201414781701 申请日期 2014.04.02
申请人 ALIOPHTHA AG 发明人 NEUTZNER Albert;FLAMMER Josef;HUXLEY Alice
分类号 C07K14/47 主分类号 C07K14/47
代理机构 代理人
主权项 1. An artificial transcription factor comprising a polydactyl zinc finger protein targeting specifically a gene promoter fused to an activatory or inhibitory protein domain, a nuclear localization sequence, a protein transduction domain, and an endosome-specific protease recognition site.
地址 Basel CH